"Inflammation Control Paramount in Pregnant IBD Patients" - Diana Swift
The American Gastroenterological Association (AGA) has issued a new report designed to standardize the management of inflammatory bowel disease (IBD) in pregnancy. Pregnancy and IBD were once considered a risky combination, however the proliferation of therapeutic options in the past 15 years has given hope to IBD patients who wish to bear children. “Control of the inflammation of the mother will improve outcomes for the child," said study co-author Marla Dubinsky, MD and co-director of The Susan and Leonard Feinstein Inflammatory Bowel Disease Center, and professor of pediatrics and gastroenterology at of the Icahn School of Medicine at Mount Sinai. A major focal point of the report is preconception counseling to ensure disease control in the advanced stages of pregnancy. "The most important part of care is to get the IBD into deep remission, since even subtle, subclinical disease can impact everything from getting pregnant to the postpartum period," Dr. Dubinsky added.
— Marla C. Dubinsky, MD, Professor, Medicine, Gastroenterology, Pediatrics, Icahn School of Medicine at Mount Sinai, Chief, Division of Pediatric Gastroenterology, Mount Sinai Kravis Children’s Hospital, Co-Director, The Susan and Leonard Feinstein Inflammatory Bowel Disease Center